name:-0.036550045013428
name:-0.01292896270752
name:-0.0025551319122314
Dwyer; Michael Patent Filings

Dwyer; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dwyer; Michael.The latest application filed is for "system and method for supplying compressed air to a main engine starter motor".

Company Profile
3.15.27
  • Dwyer; Michael - Phoenix AZ
  • Dwyer; Michael - Scotch Plains NJ
  • Dwyer; Michael - Scoth Plains NJ
  • Dwyer; Michael - El Dorado Hills CA
  • Dwyer; Michael - Franklin WI
  • Dwyer; Michael - Fort Myers FL
  • Dwyer; Michael -
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
System and method for supplying compressed air to a main engine starter motor
Grant 11,339,721 - Riley , et al. May 24, 2
2022-05-24
System And Method For Supplying Compressed Air To A Main Engine Starter Motor
App 20200149476 - Riley; Harold ;   et al.
2020-05-14
Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases
Grant 10,646,494 - Yu , et al.
2020-05-12
Heterocycle-substituted Tetracyclic Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases
App 20190175602 - Yu; Wensheng ;   et al.
2019-06-13
Systems and methods for controlling aircraft main engine speeds by adjusting compressed air flow from an APU
Grant 9,567,906 - Nesdill , et al. February 14, 2
2017-02-14
Thiophene-substituted Tetracyclic Compounds And Methods Ofuse Thereof For The Treatment Of Viral Diseases
App 20160257697 - Tong; Ling ;   et al.
2016-09-08
Systems And Methods For Controlling Aircraft Main Engine Speeds
App 20150167553 - Nesdill; Thomas ;   et al.
2015-06-18
Morpholinone compounds as factor IXA inhibitors
Grant 8,987,242 - Chackalamannil , et al. March 24, 2
2015-03-24
Morpholinone compounds as factor IXa inhibitors
Grant 8,642,582 - Nishida , et al. February 4, 2
2014-02-04
4, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitors
Grant 8,609,676 - Chelliah , et al. December 17, 2
2013-12-17
4, 5, 6-trisubstituted Pyrimidine Derivatives As Factor Ixa Inhibitors
App 20120136016 - Chelliah; Mariappan V. ;   et al.
2012-05-31
3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands
App 20110213029 - Taveras; Arthur G. ;   et al.
2011-09-01
3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
Grant 7,964,646 - Taveras , et al. June 21, 2
2011-06-21
Morpholinone Compounds As Factor Ixa Inhibitors
App 20110135650 - CHACKALAMANNIL; Samuel ;   et al.
2011-06-09
3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
Grant 7,947,720 - Taveras , et al. May 24, 2
2011-05-24
Morpholinone Compounds As Factor Ixa Inhibitors
App 20110059958 - Nishida; Hidemitsu ;   et al.
2011-03-10
Scalable parallel pipeline floating-point unit for vector processing
Grant 7,765,386 - Donofrio , et al. July 27, 2
2010-07-27
Word Game
App 20100009736 - Dwyer; Michael
2010-01-14
3,4-di-substituted Cyclobutene-1,2-diones As Cxc-chemokine Receptor Ligands
App 20090306079 - Taveras; Arthur G. ;   et al.
2009-12-10
Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand
App 20080279822 - Hu; Mengwei ;   et al.
2008-11-13
Method and apparatus for processing of heterogeneous units of work
App 20070106773 - Gallino; Jeffrey A. ;   et al.
2007-05-10
Method and apparatus for processing heterogeneous units of work
App 20070094023 - Gallino; Jeffrey A. ;   et al.
2007-04-26
Method and apparatus for the processing of heterogeneous units of work
App 20070094270 - Gallino; Jeffrey A. ;   et al.
2007-04-26
Scalable parallel pipeline floating-point unit for vector processing
App 20070074009 - Donofrio; David D. ;   et al.
2007-03-29
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
App 20070021494 - Taveras; Arthur G. ;   et al.
2007-01-25
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
Grant 7,132,445 - Taveras , et al. November 7, 2
2006-11-07
Method of facilitating social communication
App 20060229901 - Dwyer; Michael G. ;   et al.
2006-10-12
Crystalline polymorphs of a CXC-chemokine receptor ligand
App 20050192345 - Hu, Mengwei ;   et al.
2005-09-01
3,4-di-substituted maleimide compounds as CXC chemokine receptor antagonists
Grant 6,903,131 - Taveras , et al. June 7, 2
2005-06-07
3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists
Grant 6,878,709 - Taveras , et al. April 12, 2
2005-04-12
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
App 20040235908 - Taveras, Arthur G. ;   et al.
2004-11-25
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
App 20040147559 - Taveras, Arthur G. ;   et al.
2004-07-29
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
App 20040106794 - Taveras, Arthur G. ;   et al.
2004-06-03
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
App 20040097547 - Taveras, Arthur G. ;   et al.
2004-05-20
3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists
App 20040063709 - Taveras, Arthur G. ;   et al.
2004-04-01
3,4-Di-substituted maleimide compounds as CXC chemokine receptor antagonists
App 20040034229 - Taveras, Arthur G. ;   et al.
2004-02-19
3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
App 20030204085 - Taveras, Arthur G. ;   et al.
2003-10-30
3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists
App 20030097004 - Taveras, Arthur G. ;   et al.
2003-05-22
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed